Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor

Journal of Chemotherapy

Volumn 11, Issue 3, 1999, Pages 211-214

  Umut, S ^a   Tutluoglu B ^a,b   Tosun, G Aydin ^a   Musellim B ^a   Erk, M ^a   Yildirim, N ^a   Vahapoglu H ^a   Yilmaz, N ^a   Arseven, O ^a   Turker H ^a   Erelel, M ^a   Ilvan, A ^a   Goylusun V ^a   Kuyucu, T Yilmaz ^a   Kosar F ^a   Soysal, F ^a   Gur A ^a   Unutmaz, S ^a   Ozturk S ^a   Akman, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Arvtan Apt   (Turkey)

Author keywords

Antibiotic treatment; Azithromycin; Cefaclor monohydrate; Ciprofloxacin; COPD; Respiratory infections; Suitamicillin

Indexed keywords

AZITHROMYCIN; CEFACLOR; CIPROFLOXACIN; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0033033662     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.3.211     Document Type: Article

References (12)

1. Siafakas NM, Vermeire P et al. Optimal assessment and management of COPD. Eur Resp J 1995; 8: 1398-1420.
2. American Thoracic Society (ATS) Statement. Standards for the diagnosis and care of patients with Chronic Obstructive Pulmonary disease. Am J Respir Crit Care Med 1995; 152(5): 78s-121s.
3. Fagon JY, Chastre J. Severe exacerbations of COPD patients: The role of pulmonary infections. Semin Respir Infect 1996; 11(2): 109-118.
4. Wilson R. The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline. Rev Contemp Pharmacother 1992; 3: 103-112.
5. Devalia JL, Grady D, Harmanyeri Ytabaqchali S, Davies RJ. Histamine synthesis by respiratory tract microorganisms: possible role in pathogenicity. J Clin Pathol 1989; 42: 516-522.
6. Davies BI, Maesen FP. The epidemiology of respiratory tract pathogens in Southern Netherland. Eur Resp J 1988; 1: 415-420.
7. Cole P. Evaluating clinical outcomes of respiratory infection. Int J Antimicrob Agents 1993; Suppl 1: S15-19.
8. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in COPD. Am J Resp Crit Care Med 1995; 152: 1316-1320.
9. Verghes A, Berk SL. Branhamella catarrhalis: a microbiological and clinical update. Am J Med 1990; 88: 5A.
10. Anthonisen NR, Manfreada J, Warren CPW, Hershfield ES, Harding, Nelson NA. Antibiotic therapy in exacerbations of COPD. Ann Intern Med 1987; 106: 196-204.
11. Saint S, Bent S, Vittinghof E, Grady D. Antibiotics in COPD exacerbations. A meta analysis. JAMA 1995; 273: 957-960.
12. Sportel JH, Koeter GH, van Altena R, Löwenberg A, Boersma WG. Relation between beta-lactamase producing bacteria and patient characteristics in COPD. Thorax 1995; 50: 249-253.